CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108. A total of 45 filers reported holding CONATUS PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 1.80 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $62,000 | -3.1% | 57,523 | +54.6% | 0.00% | – |
| Q4 2018 | $64,000 | +6.7% | 37,216 | +258.0% | 0.00% | – |
| Q3 2018 | $60,000 | +3.4% | 10,396 | -24.1% | 0.00% | – |
| Q2 2018 | $58,000 | +314.3% | 13,688 | +439.1% | 0.00% | -100.0% |
| Q2 2017 | $14,000 | -95.1% | 2,539 | -94.9% | 0.00% | -91.7% |
| Q1 2017 | $286,000 | +3475.0% | 49,610 | +1021.1% | 0.01% | +1100.0% |
| Q3 2016 | $8,000 | +700.0% | 4,425 | +747.7% | 0.00% | – |
| Q4 2015 | $1,000 | – | 522 | +656.5% | 0.00% | – |
| Q2 2015 | $0 | -100.0% | 69 | -87.4% | 0.00% | – |
| Q4 2014 | $4,000 | – | 546 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|